Caption Management, LLC Arcutis Biotherapeutics, Inc. Put Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$7.24 - $12.53 $1.62 Million - $2.8 Million
-223,400 Reduced 59.83%
150,000 $1.4 Million
Q1 2024

May 15, 2024
BUY
$3.25 - $11.77 $1.21 Million - $4.39 Million
373,400 New
373,400 $3.7 Million
Q2 2023

Aug 14, 2023
BUY
$7.51 - $15.0 $638,350 - $1.28 Million
85,000 New
85,000 $810,000
Q2 2022

Aug 15, 2022
BUY
$16.33 - $22.2 $816,499 - $1.11 Million
50,000 New
50,000 $1.07 Million

Others Institutions Holding ARQT

# of Institutions
196
Shares Held
130M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $797M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email